BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616 AND Prognosis
8 results:

  • 1. colorectal Carcinoma With Sarcomatoid Components: Report of 15 Cases and Literature Review of an Exceedingly Rare Carcinoma Subtype.
    Golconda U; McHugh KE; Allende DS; Collins K; Henn P; Lacambra M; Bejarano PA; Groisman GM; Loughrey MB; Monappa V; Zhang X; Hornick JL; Gonzalez RS
    Am J Surg Pathol; 2024 Apr; 48(4):465-474. PubMed ID: 38155543
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Clinicopathological characteristics of gastric smarca4-deficient undifferentiated/rhabdoid carcinoma].
    Wu JY; Jiang K; Yan LJ; Yin LS; Huang XZ; Jia L; Sun Y
    Zhonghua Bing Li Xue Za Zhi; 2023 May; 52(5):447-453. PubMed ID: 37106285
    [No Abstract]    [Full Text] [Related]  

  • 3. JNK pathway plays a critical role for expansion of human colorectal cancer in the context of brg1 suppression.
    Yoshikawa T; Fukuda A; Omatsu M; Namikawa M; Sono M; Fukunaga Y; Masuda T; Araki O; Nagao M; Ogawa S; Masuo K; Goto N; Hiramatsu Y; Muta Y; Tsuda M; Maruno T; Nakanishi Y; Kawada K; Takaishi S; Seno H
    Cancer Sci; 2022 Oct; 113(10):3417-3427. PubMed ID: 35924439
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. MiR-6511b-5p suppresses metastasis of pMMR colorectal cancer through methylation of CD44 by directly targeting brg1.
    Sun J; Ye L; Shi Y; Wang X; Zhao X; Ren S; Fan J; Shao H; Qin B
    Clin Transl Oncol; 2022 Oct; 24(10):1940-1953. PubMed ID: 35590122
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. NUTM1-rearranged colorectal sarcoma: a clinicopathologically and genetically distinctive malignant neoplasm with a poor prognosis.
    Van Treeck BJ; Thangaiah JJ; Torres-Mora J; Stevens TM; Rothermundt C; Fassan M; Loupakis F; Diebold J; Hornick JL; Halling KC; Folpe AL
    Mod Pathol; 2021 Aug; 34(8):1547-1557. PubMed ID: 33714983
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Characterization of genomic alterations in Chinese colorectal cancer patients.
    Huang W; Li H; Shi X; Lin M; Liao C; Zhang S; Shi W; Zhang L; Zhang X; Gan J
    Jpn J Clin Oncol; 2021 Jan; 51(1):120-129. PubMed ID: 33106877
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. brg1 is correlated with poor prognosis in colorectal cancer.
    Pyo JS; Son BK; Oh D; Kim EK
    Hum Pathol; 2018 Mar; 73():66-73. PubMed ID: 29288038
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The chromatin-remodeling enzyme brg1 promotes colon cancer progression via positive regulation of WNT3A.
    Lin S; Jiang T; Ye L; Han Z; Liu Y; Liu C; Yuan C; Zhao S; Chen J; Wang J; Tang H; Lu S; Yang L; Wang X; Yan D; Peng Z; Fan J
    Oncotarget; 2016 Dec; 7(52):86051-86063. PubMed ID: 27852072
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.